Detailed Information on Publication Record
2014
NOS3 894G > T Polymorphism is Associated With Progression of Kidney Disease and Cardiovascular Morbidity in Type 2 Diabetic Patients: NOS3 as a Modifier Gene for Diabetic Nephropathy?
KURICOVÁ, Katarína, Veronika DVOŘÁKOVÁ, Lukáš PÁCAL, Vendula BARTÁKOVÁ, Lucie BROŽOVÁ et. al.Basic information
Original name
NOS3 894G > T Polymorphism is Associated With Progression of Kidney Disease and Cardiovascular Morbidity in Type 2 Diabetic Patients: NOS3 as a Modifier Gene for Diabetic Nephropathy?
Authors
KURICOVÁ, Katarína (703 Slovakia, belonging to the institution), Veronika DVOŘÁKOVÁ (203 Czech Republic, belonging to the institution), Lukáš PÁCAL (203 Czech Republic, guarantor, belonging to the institution), Vendula BARTÁKOVÁ (203 Czech Republic, belonging to the institution), Lucie BROŽOVÁ (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution) and Kateřina KAŇKOVÁ (203 Czech Republic, belonging to the institution)
Edition
Kidney and Blood Pressure Research, Karger, 2014, 1420-4096
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30105 Physiology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 2.123
RIV identification code
RIV/00216224:14110/14:00080127
Organization unit
Faculty of Medicine
UT WoS
000334181300010
Keywords in English
Diabetic nephropathy; Nitric oxide synthase; Polymorphism; Cardiovascular morbidity
Tags
Tags
International impact, Reviewed
Změněno: 24/4/2015 14:29, Soňa Böhmová
Abstract
V originále
Background/Aims: We have previously associated SNP 894G>T in the NOS3 gene with diabetic nephropathy (DN) using multi-locus analysis. Variant 894G>T has been widely studied as a DN susceptibility factor with contradictory results. In the present study we genotyped 894G>T in the cohort of prospectively followed type 2 diabetics with the aim to investigate its possible role in the progression of DN and development of morbidity and mortality associated with diabetes. Methods: 311 subjects with defined stage of DN were enrolled in the study and followed up for a median of 38 months. We considered three end-points: progression of DN, major cardiovascular event and all-cause mortality. Results: Considering baseline GFR, age at enrolment and diabetes duration as confounders, Cox regression analysis identified 894GTgenotype as a risk factor for DN progression (HR = 1.843 [95% CI 1.088 – 3.119], P = 0.023) and 894TT genotype as a risk factor for major cardiovascular event (HR = 2.515 [95% CI 1.060 – 5.965], P = 0.036). Conclusion: We ascertained the significant effect of the NOS3 894G>T variant on DN progression and occurrence of major cardiovascular event in T2DM subjects. Based on these results NOS3 can be considered a modifier gene for DN.
Links
NT11405, research and development project |
|